EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.

Fan, Kui; Zhang, Bo-Hui; Han, Deng; Sun, Yun-Chuan

Fan, Kui; Zhang, Bo-Hui; Han, Deng; Sun, Yun-Chuan.

Afiliación

Fan K; Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine-Hebei Province, No. 31, Huanghe West Road, Yunhe District, Cangzhou, 061000, Hebei, China.
Zhang BH; Department of Neurology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine-Hebei Province, Cangzhou, 061000, Hebei, China.
Han D; Division of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100105, China.
Sun YC; Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine-Hebei Province, No. 31, Huanghe West Road, Yunhe District, Cangzhou, 061000, Hebei, China. sunyunchuan@163.com.

BMC Bioinformatics ; 24(1): 149, 2023 Apr 17.

Article en En | MEDLINE | ID: mdl-37069494

Asunto(s)

Adenocarcinoma del Pulmón; Neoplasias Pulmonares; Humanos; Proteína Potenciadora del Homólogo Zeste 2/genética; Pronóstico; Proteínas Proto-Oncogénicas p21(ras); Ciclo Celular; Adenocarcinoma del Pulmón/genética; Neoplasias Pulmonares/genética; Biomarcadores

Palabras clave

EZH2; LUAD; Prognosis; Tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BMC Bioinformatics Asunto de la revista: INFORMATICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google